Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of the Efficacy of Intralipid Treatment in Patients With Recurrent Implantation Failure and Miscarriages With High Peripheral and Uterine Natural Killer Cells

NCT01679561 is registered in ClinicalTrials.gov with Woman's Health University Hospital, Egypt as lead sponsor.

NCT NCT01679561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01679561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of the Efficacy of Intralipid Treatment in Patients With Recurrent Implantation Failure and Miscarriages With High Peripheral and Uterine Natural Killer Cells
Lead sponsor
Woman's Health University Hospital, Egypt
Phase
Phase 4
Overall status
Withdrawn
Start date
February 29, 2012
Completion date
December 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy complicated by low implantation